Tech Company M&A Transactions
MedImmune Acquisition
Headquartered in Gaithersburg, MedImmune was acquired by AstraZeneca. Deal value was $15.6 billion.
Transaction Overview
Company Name
Acquired By
Announced On
4/23/2007
Transaction Type
M&A
Amount
$15,600,000,000
M&A Terms
Under the terms of the agreement, which has unanimous MedImmune Board support, AstraZeneca will acquire all of the fully diluted shares of MedImmune common stock at a price of $58 per share, for a total consideration of approximately $15.6 billion (including approximately $340m net cash).
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Medimmune Way
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Website
Email Address
Overview
At MedImmune our core therapeutic areas are Oncology; Respiratory, Inflammation & Autoimmune, and Cardiovascular & Metabolic Disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Matthew Bell
President
Bahija Jallal
Vice President
Scott Alban
Vice President
Badrul Chowdhury
Vice President
Mohammed Dar
VP - Bus. Development
Gail Folena-Wasserman
VP - Finance
James Brady
VP - R & D
Jane Osbourn
VP - R & D
Cristina Rondinone
VP - R & D
Jean-Charles Soria
VP - R & D
JoAnn Suzich
VP - Regulatory Affairs
Tracy Rossin
Browse more venture capital transactions:
Prev: 4/23/2007: AmberPoint venture capital transaction
Next: 4/23/2007: Acclarent venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs